Biological Additive Manufacturing Capabilities for Enabling Rapid Response to Emerging Pathogens

Matthew Coleman | 21-ERD-039

Executive Summary

We will develop a first-of-its-kind engineered platform to perform protein production, binding, and affinity measurements in a fraction of the time required by current methods. The technology will provide a truly rapid response pipeline for producing and investigating biothreat-related proteins such as SARS-COVID and Ebola viruses.